STK11 and non-small cell lung carcinoma: NSCLC patients carrying STK11/LKB1 mutations are more likely to have an inferior prognosis than those withoutSTK11/LKB1 mutation, and specifically, STK11/LKB1 mutations have been closely associated with poor prognosis in NSCLC (Rosellini et al., 2022; Sumbly and Landry, 2022).